We analyzed 156 primary neuroblastoma tumor samples for loss of hetero
zygosity at the distal short arm of chromosome 1 (1p LOH). We also com
pared Ip LOH with known clinical and genetic prognostic variables as w
ell as patient outcome, Ip LOH was detected in 30 of 156 tumors (19%)
and was strongly associated with adverse clinical and biological featu
res. 1p LOH was also strongly predictive of a poor outcome in univaria
te analyses (estimated 4-year survival, 32 +/- 10% SE versus 76 +/- 5%
SE; P < 0.001). However, the prognostic value of Ip LOH was equivocal
when stratified for amplification of the MYCN oncogene (P = 0.16). We
conclude that 1p LOH is an important component of a pattern of geneti
c abnormalities in neuroblastoma associated with an aggressive clinica
l course.